Multiple Myeloma is a cancer that affects plasma cells in bone marrow. Abnormal plasma cells produce harmful proteins, leading to anemia, bone pain, frequent infections, and kidney failure. Treatment includes plasma cell-directed therapy, often a combination of drugs, and advancements like bone marrow transplants and CAR-T cell therapy. These innovations have significantly improved patient outcomes, extending survival rates and bringing hope for a future cure. Join Dr. Jason Howland as he explains the latest developments and the promising future for multiple myeloma patients.